Mutations in key cancer protein suggest new route to treatments
November 24, 2015
Researchers found they could disrupt STAT3's ability to act as a transcription factor by altering part of the protein, which interfered with its cancer-promoting activity. The findings suggest a basis for new, targeted approaches to fighting cancer.
Leave a comment